1. Home
  2. ABEO vs TATT Comparison

ABEO vs TATT Comparison

Compare ABEO & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • TATT
  • Stock Information
  • Founded
  • ABEO N/A
  • TATT 1985
  • Country
  • ABEO United States
  • TATT Israel
  • Employees
  • ABEO N/A
  • TATT N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • TATT Aerospace
  • Sector
  • ABEO Health Care
  • TATT Industrials
  • Exchange
  • ABEO Nasdaq
  • TATT Nasdaq
  • Market Cap
  • ABEO 247.8M
  • TATT 209.6M
  • IPO Year
  • ABEO 1980
  • TATT 1987
  • Fundamental
  • Price
  • ABEO $5.70
  • TATT $26.09
  • Analyst Decision
  • ABEO Strong Buy
  • TATT
  • Analyst Count
  • ABEO 3
  • TATT 0
  • Target Price
  • ABEO $18.00
  • TATT N/A
  • AVG Volume (30 Days)
  • ABEO 229.2K
  • TATT 48.9K
  • Earning Date
  • ABEO 11-14-2024
  • TATT 11-18-2024
  • Dividend Yield
  • ABEO N/A
  • TATT N/A
  • EPS Growth
  • ABEO N/A
  • TATT 43.74
  • EPS
  • ABEO N/A
  • TATT 0.76
  • Revenue
  • ABEO N/A
  • TATT $142,909,000.00
  • Revenue This Year
  • ABEO N/A
  • TATT $33.56
  • Revenue Next Year
  • ABEO $18,714.71
  • TATT $14.09
  • P/E Ratio
  • ABEO N/A
  • TATT $34.34
  • Revenue Growth
  • ABEO 147.52
  • TATT 36.36
  • 52 Week Low
  • ABEO $3.05
  • TATT $10.02
  • 52 Week High
  • ABEO $9.01
  • TATT $27.69
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 34.30
  • TATT 64.42
  • Support Level
  • ABEO $5.45
  • TATT $24.94
  • Resistance Level
  • ABEO $6.04
  • TATT $27.36
  • Average True Range (ATR)
  • ABEO 0.19
  • TATT 1.40
  • MACD
  • ABEO -0.04
  • TATT -0.05
  • Stochastic Oscillator
  • ABEO 19.47
  • TATT 72.63

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.

Share on Social Networks: